Pharma & Healthcare

Secondary Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

The global market for Secondary Antibody was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Secondary Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Secondary Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Secondary Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Secondary Antibody include Biorbyt, Bio-Rad, SouthernBiotech, Thermo Fisher Scientific, Miltenyi Biotec, Abcam, Novus Biologicals, Bio-Techne and Rockland Immunochemicals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Secondary Antibody, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Secondary Antibody by region & country, by Type, and by Application.
The Secondary Antibody market size, estimations, and forecasts are provided in terms of sales volume (mg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Secondary Antibody.
Market Segmentation
By Company
Biorbyt
Bio-Rad
SouthernBiotech
Thermo Fisher Scientific
Miltenyi Biotec
Abcam
Novus Biologicals
Bio-Techne
Rockland Immunochemicals
Proteintech
Genscript Biotech
Boster Bio
Advansta Inc
Creative Diagnostics
Segment by Type:
IgG
IgM
IgA
IgE
IgD
Segment by Application
Hospital
Life Sciences
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Secondary Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Secondary Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Secondary Antibody in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Secondary Antibody Product Introduction
1.2 Global Secondary Antibody Market Size Forecast
1.2.1 Global Secondary Antibody Sales Value (2019-2030)
1.2.2 Global Secondary Antibody Sales Volume (2019-2030)
1.2.3 Global Secondary Antibody Sales Price (2019-2030)
1.3 Secondary Antibody Market Trends & Drivers
1.3.1 Secondary Antibody Industry Trends
1.3.2 Secondary Antibody Market Drivers & Opportunity
1.3.3 Secondary Antibody Market Challenges
1.3.4 Secondary Antibody Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Secondary Antibody Players Revenue Ranking (2023)
2.2 Global Secondary Antibody Revenue by Company (2019-2024)
2.3 Global Secondary Antibody Players Sales Volume Ranking (2023)
2.4 Global Secondary Antibody Sales Volume by Company Players (2019-2024)
2.5 Global Secondary Antibody Average Price by Company (2019-2024)
2.6 Key Manufacturers Secondary Antibody Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Secondary Antibody Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Secondary Antibody
2.9 Secondary Antibody Market Competitive Analysis
2.9.1 Secondary Antibody Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Secondary Antibody Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Secondary Antibody as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 IgG
3.1.2 IgM
3.1.3 IgA
3.1.4 IgE
3.1.5 IgD
3.2 Global Secondary Antibody Sales Value by Type
3.2.1 Global Secondary Antibody Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Secondary Antibody Sales Value, by Type (2019-2030)
3.2.3 Global Secondary Antibody Sales Value, by Type (%) (2019-2030)
3.3 Global Secondary Antibody Sales Volume by Type
3.3.1 Global Secondary Antibody Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Secondary Antibody Sales Volume, by Type (2019-2030)
3.3.3 Global Secondary Antibody Sales Volume, by Type (%) (2019-2030)
3.4 Global Secondary Antibody Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Life Sciences
4.1.3 Laboratory
4.2 Global Secondary Antibody Sales Value by Application
4.2.1 Global Secondary Antibody Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Secondary Antibody Sales Value, by Application (2019-2030)
4.2.3 Global Secondary Antibody Sales Value, by Application (%) (2019-2030)
4.3 Global Secondary Antibody Sales Volume by Application
4.3.1 Global Secondary Antibody Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Secondary Antibody Sales Volume, by Application (2019-2030)
4.3.3 Global Secondary Antibody Sales Volume, by Application (%) (2019-2030)
4.4 Global Secondary Antibody Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Secondary Antibody Sales Value by Region
5.1.1 Global Secondary Antibody Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Secondary Antibody Sales Value by Region (2019-2024)
5.1.3 Global Secondary Antibody Sales Value by Region (2025-2030)
5.1.4 Global Secondary Antibody Sales Value by Region (%), (2019-2030)
5.2 Global Secondary Antibody Sales Volume by Region
5.2.1 Global Secondary Antibody Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Secondary Antibody Sales Volume by Region (2019-2024)
5.2.3 Global Secondary Antibody Sales Volume by Region (2025-2030)
5.2.4 Global Secondary Antibody Sales Volume by Region (%), (2019-2030)
5.3 Global Secondary Antibody Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Secondary Antibody Sales Value, 2019-2030
5.4.2 North America Secondary Antibody Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Secondary Antibody Sales Value, 2019-2030
5.5.2 Europe Secondary Antibody Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Secondary Antibody Sales Value, 2019-2030
5.6.2 Asia Pacific Secondary Antibody Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Secondary Antibody Sales Value, 2019-2030
5.7.2 South America Secondary Antibody Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Secondary Antibody Sales Value, 2019-2030
5.8.2 Middle East & Africa Secondary Antibody Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Secondary Antibody Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Secondary Antibody Sales Value
6.2.1 Key Countries/Regions Secondary Antibody Sales Value, 2019-2030
6.2.2 Key Countries/Regions Secondary Antibody Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Secondary Antibody Sales Value, 2019-2030
6.3.2 United States Secondary Antibody Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Secondary Antibody Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Secondary Antibody Sales Value, 2019-2030
6.4.2 Europe Secondary Antibody Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Secondary Antibody Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Secondary Antibody Sales Value, 2019-2030
6.5.2 China Secondary Antibody Sales Value by Type (%), 2023 VS 2030
6.5.3 China Secondary Antibody Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Secondary Antibody Sales Value, 2019-2030
6.6.2 Japan Secondary Antibody Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Secondary Antibody Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Secondary Antibody Sales Value, 2019-2030
6.7.2 South Korea Secondary Antibody Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Secondary Antibody Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Secondary Antibody Sales Value, 2019-2030
6.8.2 Southeast Asia Secondary Antibody Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Secondary Antibody Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Secondary Antibody Sales Value, 2019-2030
6.9.2 India Secondary Antibody Sales Value by Type (%), 2023 VS 2030
6.9.3 India Secondary Antibody Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biorbyt
7.1.1 Biorbyt Company Information
7.1.2 Biorbyt Introduction and Business Overview
7.1.3 Biorbyt Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Biorbyt Secondary Antibody Product Offerings
7.1.5 Biorbyt Recent Development
7.2 Bio-Rad
7.2.1 Bio-Rad Company Information
7.2.2 Bio-Rad Introduction and Business Overview
7.2.3 Bio-Rad Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bio-Rad Secondary Antibody Product Offerings
7.2.5 Bio-Rad Recent Development
7.3 SouthernBiotech
7.3.1 SouthernBiotech Company Information
7.3.2 SouthernBiotech Introduction and Business Overview
7.3.3 SouthernBiotech Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.3.4 SouthernBiotech Secondary Antibody Product Offerings
7.3.5 SouthernBiotech Recent Development
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Information
7.4.2 Thermo Fisher Scientific Introduction and Business Overview
7.4.3 Thermo Fisher Scientific Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Thermo Fisher Scientific Secondary Antibody Product Offerings
7.4.5 Thermo Fisher Scientific Recent Development
7.5 Miltenyi Biotec
7.5.1 Miltenyi Biotec Company Information
7.5.2 Miltenyi Biotec Introduction and Business Overview
7.5.3 Miltenyi Biotec Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Miltenyi Biotec Secondary Antibody Product Offerings
7.5.5 Miltenyi Biotec Recent Development
7.6 Abcam
7.6.1 Abcam Company Information
7.6.2 Abcam Introduction and Business Overview
7.6.3 Abcam Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Abcam Secondary Antibody Product Offerings
7.6.5 Abcam Recent Development
7.7 Novus Biologicals
7.7.1 Novus Biologicals Company Information
7.7.2 Novus Biologicals Introduction and Business Overview
7.7.3 Novus Biologicals Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Novus Biologicals Secondary Antibody Product Offerings
7.7.5 Novus Biologicals Recent Development
7.8 Bio-Techne
7.8.1 Bio-Techne Company Information
7.8.2 Bio-Techne Introduction and Business Overview
7.8.3 Bio-Techne Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bio-Techne Secondary Antibody Product Offerings
7.8.5 Bio-Techne Recent Development
7.9 Rockland Immunochemicals
7.9.1 Rockland Immunochemicals Company Information
7.9.2 Rockland Immunochemicals Introduction and Business Overview
7.9.3 Rockland Immunochemicals Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Rockland Immunochemicals Secondary Antibody Product Offerings
7.9.5 Rockland Immunochemicals Recent Development
7.10 Proteintech
7.10.1 Proteintech Company Information
7.10.2 Proteintech Introduction and Business Overview
7.10.3 Proteintech Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Proteintech Secondary Antibody Product Offerings
7.10.5 Proteintech Recent Development
7.11 Genscript Biotech
7.11.1 Genscript Biotech Company Information
7.11.2 Genscript Biotech Introduction and Business Overview
7.11.3 Genscript Biotech Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Genscript Biotech Secondary Antibody Product Offerings
7.11.5 Genscript Biotech Recent Development
7.12 Boster Bio
7.12.1 Boster Bio Company Information
7.12.2 Boster Bio Introduction and Business Overview
7.12.3 Boster Bio Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Boster Bio Secondary Antibody Product Offerings
7.12.5 Boster Bio Recent Development
7.13 Advansta Inc
7.13.1 Advansta Inc Company Information
7.13.2 Advansta Inc Introduction and Business Overview
7.13.3 Advansta Inc Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Advansta Inc Secondary Antibody Product Offerings
7.13.5 Advansta Inc Recent Development
7.14 Creative Diagnostics
7.14.1 Creative Diagnostics Company Information
7.14.2 Creative Diagnostics Introduction and Business Overview
7.14.3 Creative Diagnostics Secondary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Creative Diagnostics Secondary Antibody Product Offerings
7.14.5 Creative Diagnostics Recent Development
8 Industry Chain Analysis
8.1 Secondary Antibody Industrial Chain
8.2 Secondary Antibody Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Secondary Antibody Sales Model
8.5.2 Sales Channel
8.5.3 Secondary Antibody Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Secondary Antibody Market Trends
Table 2. Secondary Antibody Market Drivers & Opportunity
Table 3. Secondary Antibody Market Challenges
Table 4. Secondary Antibody Market Restraints
Table 5. Global Secondary Antibody Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Secondary Antibody Revenue Market Share by Company (2019-2024)
Table 7. Global Secondary Antibody Sales Volume by Company (2019-2024) & (mg)
Table 8. Global Secondary Antibody Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Secondary Antibody Price by Company (2019-2024) & (USD/mg)
Table 10. Key Manufacturers Secondary Antibody Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Secondary Antibody Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Secondary Antibody
Table 13. Global Secondary Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Secondary Antibody as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Secondary Antibody Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Secondary Antibody Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Secondary Antibody Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Secondary Antibody Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Secondary Antibody Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Secondary Antibody Sales Volume by Type: 2019 VS 2023 VS 2030 (mg)
Table 22. Global Secondary Antibody Sales Volume by Type (2019-2024) & (mg)
Table 23. Global Secondary Antibody Sales Volume by Type (2025-2030) & (mg)
Table 24. Global Secondary Antibody Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Secondary Antibody Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Secondary Antibody Price by Type (2019-2024) & (USD/mg)
Table 27. Global Secondary Antibody Price by Type (2025-2030) & (USD/mg)
Table 28. Global Secondary Antibody Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Secondary Antibody Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Secondary Antibody Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Secondary Antibody Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Secondary Antibody Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Secondary Antibody Sales Volume by Application: 2019 VS 2023 VS 2030 (mg)
Table 34. Global Secondary Antibody Sales Volume by Application (2019-2024) & (mg)
Table 35. Global Secondary Antibody Sales Volume by Application (2025-2030) & (mg)
Table 36. Global Secondary Antibody Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Secondary Antibody Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Secondary Antibody Price by Application (2019-2024) & (USD/mg)
Table 39. Global Secondary Antibody Price by Application (2025-2030) & (USD/mg)
Table 40. Global Secondary Antibody Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Secondary Antibody Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Secondary Antibody Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Secondary Antibody Sales Value by Region (2019-2024) & (%)
Table 44. Global Secondary Antibody Sales Value by Region (2025-2030) & (%)
Table 45. Global Secondary Antibody Sales Volume by Region (mg): 2019 VS 2023 VS 2030
Table 46. Global Secondary Antibody Sales Volume by Region (2019-2024) & (mg)
Table 47. Global Secondary Antibody Sales Volume by Region (2025-2030) & (mg)
Table 48. Global Secondary Antibody Sales Volume by Region (2019-2024) & (%)
Table 49. Global Secondary Antibody Sales Volume by Region (2025-2030) & (%)
Table 50. Global Secondary Antibody Average Price by Region (2019-2024) & (USD/mg)
Table 51. Global Secondary Antibody Average Price by Region (2025-2030) & (USD/mg)
Table 52. Key Countries/Regions Secondary Antibody Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Secondary Antibody Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Secondary Antibody Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Secondary Antibody Sales Volume, (2019-2024) & (mg)
Table 56. Key Countries/Regions Secondary Antibody Sales Volume, (2025-2030) & (mg)
Table 57. Biorbyt Company Information
Table 58. Biorbyt Introduction and Business Overview
Table 59. Biorbyt Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 60. Biorbyt Secondary Antibody Product Offerings
Table 61. Biorbyt Recent Development
Table 62. Bio-Rad Company Information
Table 63. Bio-Rad Introduction and Business Overview
Table 64. Bio-Rad Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 65. Bio-Rad Secondary Antibody Product Offerings
Table 66. Bio-Rad Recent Development
Table 67. SouthernBiotech Company Information
Table 68. SouthernBiotech Introduction and Business Overview
Table 69. SouthernBiotech Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 70. SouthernBiotech Secondary Antibody Product Offerings
Table 71. SouthernBiotech Recent Development
Table 72. Thermo Fisher Scientific Company Information
Table 73. Thermo Fisher Scientific Introduction and Business Overview
Table 74. Thermo Fisher Scientific Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 75. Thermo Fisher Scientific Secondary Antibody Product Offerings
Table 76. Thermo Fisher Scientific Recent Development
Table 77. Miltenyi Biotec Company Information
Table 78. Miltenyi Biotec Introduction and Business Overview
Table 79. Miltenyi Biotec Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 80. Miltenyi Biotec Secondary Antibody Product Offerings
Table 81. Miltenyi Biotec Recent Development
Table 82. Abcam Company Information
Table 83. Abcam Introduction and Business Overview
Table 84. Abcam Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 85. Abcam Secondary Antibody Product Offerings
Table 86. Abcam Recent Development
Table 87. Novus Biologicals Company Information
Table 88. Novus Biologicals Introduction and Business Overview
Table 89. Novus Biologicals Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 90. Novus Biologicals Secondary Antibody Product Offerings
Table 91. Novus Biologicals Recent Development
Table 92. Bio-Techne Company Information
Table 93. Bio-Techne Introduction and Business Overview
Table 94. Bio-Techne Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 95. Bio-Techne Secondary Antibody Product Offerings
Table 96. Bio-Techne Recent Development
Table 97. Rockland Immunochemicals Company Information
Table 98. Rockland Immunochemicals Introduction and Business Overview
Table 99. Rockland Immunochemicals Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 100. Rockland Immunochemicals Secondary Antibody Product Offerings
Table 101. Rockland Immunochemicals Recent Development
Table 102. Proteintech Company Information
Table 103. Proteintech Introduction and Business Overview
Table 104. Proteintech Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 105. Proteintech Secondary Antibody Product Offerings
Table 106. Proteintech Recent Development
Table 107. Genscript Biotech Company Information
Table 108. Genscript Biotech Introduction and Business Overview
Table 109. Genscript Biotech Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 110. Genscript Biotech Secondary Antibody Product Offerings
Table 111. Genscript Biotech Recent Development
Table 112. Boster Bio Company Information
Table 113. Boster Bio Introduction and Business Overview
Table 114. Boster Bio Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 115. Boster Bio Secondary Antibody Product Offerings
Table 116. Boster Bio Recent Development
Table 117. Advansta Inc Company Information
Table 118. Advansta Inc Introduction and Business Overview
Table 119. Advansta Inc Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 120. Advansta Inc Secondary Antibody Product Offerings
Table 121. Advansta Inc Recent Development
Table 122. Creative Diagnostics Company Information
Table 123. Creative Diagnostics Introduction and Business Overview
Table 124. Creative Diagnostics Secondary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 125. Creative Diagnostics Secondary Antibody Product Offerings
Table 126. Creative Diagnostics Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Secondary Antibody Downstream Customers
Table 130. Secondary Antibody Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Secondary Antibody Product Picture
Figure 2. Global Secondary Antibody Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Secondary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Secondary Antibody Sales Volume (2019-2030) & (mg)
Figure 5. Global Secondary Antibody Sales Price (2019-2030) & (USD/mg)
Figure 6. Secondary Antibody Report Years Considered
Figure 7. Global Secondary Antibody Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Secondary Antibody Players Sales Volume Ranking (2023) & (mg)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Secondary Antibody Revenue in 2023
Figure 10. Secondary Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. IgG Picture
Figure 12. IgM Picture
Figure 13. IgA Picture
Figure 14. IgE Picture
Figure 15. IgD Picture
Figure 16. Global Secondary Antibody Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Secondary Antibody Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Secondary Antibody Sales Volume by Type (2019 VS 2023 VS 2030) & (mg)
Figure 19. Global Secondary Antibody Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Secondary Antibody Price by Type (2019-2030) & (USD/mg)
Figure 21. Product Picture of Hospital
Figure 22. Product Picture of Life Sciences
Figure 23. Product Picture of Laboratory
Figure 24. Global Secondary Antibody Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Secondary Antibody Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Secondary Antibody Sales Volume by Application (2019 VS 2023 VS 2030) & (mg)
Figure 27. Global Secondary Antibody Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Secondary Antibody Price by Application (2019-2030) & (USD/mg)
Figure 29. North America Secondary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Secondary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Secondary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Secondary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Secondary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Secondary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Secondary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Secondary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Secondary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Secondary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Secondary Antibody Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Secondary Antibody Sales Volume (%), (2019-2030)
Figure 41. United States Secondary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Secondary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Secondary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Secondary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Secondary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Secondary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 47. China Secondary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Secondary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 49. China Secondary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Secondary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Secondary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Secondary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Secondary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Secondary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Secondary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Secondary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Secondary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Secondary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 59. India Secondary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Secondary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 61. India Secondary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 62. Secondary Antibody Industrial Chain
Figure 63. Secondary Antibody Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies